This Under-the-Radar Healthcare Stock Might Be on Sale for the Last Time
Investors are skeptical of Hims & Hers, pushing the stock back toward 52-week lows during September's sell-off. But are they right?
Hims & Hers Health, Inc.(HIMS)
New York Stock Exchange
HIMS
$4.47
-$0.07
-1.5%
Price as of March 11, 2022, 4:00 p.m. ET
View Interactive HIMS Charts
Hims & Hers Health, Inc.
Interactive Chart
Compare HIMS Stock to Peers
| Symbol | Last Price | Market Cap | % Δ 1 Yr | % Δ 5 Yr |
|---|---|---|---|---|
|
HIMS
Hims & Hers Health, Inc.
|
$4.47 | $917M | -70.2% | |
|
NTUS |
$24.76 | $844M | -6.7% | -33.6% |
|
NAN |
$3.77 | $1B | -35.4% | 21.6% |
|
VRT |
$7.70 | $658M | 31.8% | 81.7% |
|
SMLR |
$42.50 | $288M | -60.3% | 1,316.7% |
News & Analysis: Hims & Hers Health, Inc.
2 Top Growth Stocks That Beat Expectations and Raised Guidance
Both grew their sales by more than 50% in their most recent quarters.
What UnitedHealth's Big Move Means for These Telehealth Stocks
UnitedHealth is moving into direct-to-consumer healthcare. What does the prospect of a giant new competitor mean for Teladoc and Hims & Hers Health?
What the Market Is Missing About Hims & Hers Health
This stock's share price is not matching up with the company's underlying performance. Let's investigate.
Why Hims & Hers Health Fell by Nearly 11% Today
New week, new price target decrease from an analyst.
Why Hims & Hers Health Stock Popped Today
Shares of the telehealth company rose on better-than-expected second-quarter results.
3 Growth Stocks That Took a Big Hit This Week
The stock price for each of these companies dropped more than 5% on Tuesday.
Here's the Top Under-the-Radar Telemedicine Stock to Buy Now
Looking for cheap telemedicine stocks on the move? Look no further.
